Top 4 search results for "Sutent" in Resources. To see all results and access other features, sign up for free.

... cancer, but they may be helpful as an adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus (Afinitor) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib (Sutent ...

... When this communication is disrupted, stool may sit in the intestines longer than usual.In clinical trials, constipation occurred in: 25 percent of people taking cabozantinib (Cabometyx) 29 percent of people taking lenvatinib (Lenvima) in combination with pembrolizumab (Keytruda) 23 percent of people taking sunitinib (Sutent) 20 percent of people taking ...

... Most TKIs are FDA-approved to treat RCC.Examples of TKIs include: Axitinib (Inlyta) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sorafenib (Nexavar) Sunitinib (Sutent) Tivozanib (Fotivda) Your doctor will choose a TKI depending on other treatments you’ve tried before. ...

... Without a blood supply, tumors have a harder time getting the oxygen and nutrients they need to grow.Targeted therapies used for kidney cancer include: Axitinib Belzutifan (Welireg) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib malate (Sutent) Tivozanib (Fotivda) These medicines are often part of combination treatments ...